Cargando…
Corrigendum: Controlled Human Infections As a Tool to Reduce Uncertainty in Clinical Vaccine Development
Autores principales: | Roestenberg, Meta, Kamerling, Ingrid M. C., de Visser, Saco J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383389/ https://www.ncbi.nlm.nih.gov/pubmed/30838209 http://dx.doi.org/10.3389/fmed.2019.00023 |
Ejemplares similares
-
Controlled Human Infections As a Tool to Reduce Uncertainty in Clinical Vaccine Development
por: Roestenberg, Meta, et al.
Publicado: (2018) -
Assessment of Risks Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Experimental Human Infection Studies
por: Kuiper, Vincent P, et al.
Publicado: (2020) -
How to expedite early‐phase SARS‐CoV‐2 vaccine trials in pandemic setting—A practical perspective
por: van der Plas, Johan L., et al.
Publicado: (2020) -
Money-oriented risk-takers or deliberate decision-makers: a cross-sectional survey study of participants in controlled human infection trials
por: Hoogerwerf, Marie-Astrid, et al.
Publicado: (2020) -
CORRIGENDUM: Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis
por: Felgner, Philip L., et al.
Publicado: (2014)